IDH1: Isocitrate dehydrogenase [NADP] cytoplasmic
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Catalyzes the NADP(+)-dependent oxidative decarboxylation of isocitrate (D-threo-isocitrate) to 2-ketoglutarate (2-oxoglutarate), which is required by other enzymes such as the phytanoyl-CoA dioxygenase.
- Drugs that act on it: 6
- With a US drug page: 3
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US drug page link to it. All act as: Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor.| Ivosidenib | Approved | — | Inhibitor | Boxed warning |
| Olutasidenib | Approved | — | Inhibitor | Boxed warning |
| Vorasidenib | Approved | — | Inhibitor | — |
| BAY1436032 | — | — | Inhibitor | — |
| IDH305 | — | — | Inhibitor | — |
| Safusidenib | — | — | Inhibitor | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Ollier disease
- 0.67
- Glioblastoma
- 0.66
- Glioma
- 0.64
- Maffucci syndrome
- 0.63
- Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria
- 0.55
- Low grade glioma
- 0.48
- Glioma susceptibility 1
- 0.47
- Acute myeloid leukemia by FAB classification
- 0.47
Genes and Related Targets
Complexes and families that share a gene with this target- Genes
- IDH1
- Related
- IDH1/IDH2
Drugs and mechanisms are from ChEMBL CHEMBL2007625 (CC BY-SA 3.0). Gene name, function (UniProt O75874, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets